This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kääriäinen, M. Articles by Kalimo, H. Search for Related Content PubMed PubMed Citation Articles by Kääriäinen, M. Articles by Kalimo, H.

(American Journal of Pathology. 2002;161:1023-1031.)
© 2002 American Society for Investigative Pathology

Regular Articles

Expression of 7ß1 Integrin Splicing Variants during Skeletal Muscle Regeneration

Minna Kääriäinen^*, Liisa Nissinen, Stephen Kaufman, Arnoud Sonnenberg^¶, Markku Järvinen^*, Jyrki Heino and Hannu Kalimo^||**

From the Medical School and the Institute of Medical Technology,^* University of Tampere, Tampere, Finland; the Department of Surgery, Section of Orthopaedics, Tampere University Hospital, Tampere, Finland; the Medicity Research Laboratory, Turku, Finland; the Department of Pathology,|| Turku University Hospital and University of Turku, Turku, Finland; the Paavo Nurmi Centre,^** Turku, Finland; the Department of Cell and Structural Biology, University of Illinois, Urbana, Illinois; and the Division of Cell Biology,^¶ The Netherlands Cancer Institute, Amsterdam, The Netherlands

Integrin 7ß1 is a laminin receptor, both subunits of which have alternatively spliced, developmentally regulated variants. In skeletal muscle ß1 has two major splice variants of the intracellular domain (ß1A and ß1D). 7X1 and 7X2 represent variants of the 7 ectodomain, whereas 7A and 7B are variants of the intracellular domain. Previously we showed that during early regeneration after transection injury of muscle 7 integrin mediates dynamic adhesion of myofibers along their lateral aspects to the extracellular matrix. Stable attachment of myofibers to the extracellular matrix occurs during the third week after injury, when new myotendinous junctions develop at the ends of the regenerating myofibers. Now we have analyzed the relative expression of ß1A/ß1D and 7A/7B and 7X1/7X2 isoforms during regeneration for 2 to 56 days after transection of rat soleus muscle using reverse transcriptase-polymerase chain reaction and immunohistochemistry. During early regeneration ß1A was the predominant isoform in both the muscle and scar tissue. Expression of muscle-specific ß1D was detected in regenerating myofibers from day 4 onwards, ie, when myogenic mitotic activity began to decrease, and it became more abundant with the progression of regeneration. 7B isoform predominated on day 2. Thereafter, the relative expression of 7A transcripts increased until day 7 with the concomitant appearance of 7A immunoreactivity on regenerating myofibers. Finally, 7B again became the predominant variant in highly regenerated myofibers. Similarly as in the controls, 7X1 and 7X2 isoforms were both expressed throughout the regeneration with a peak in 7X1 expression on day 4 coinciding with the dynamic adhesion stage. The results suggest that during regeneration of skeletal muscle the splicing of ß1 and 7 integrin subunits is regulated according to functional requirements. 7A and 7X1 appear to have a specific role during the dynamic phase of adhesion, whereas 7B, 7X2, and ß1D predominate during stable adhesion.

This article has been cited by other articles:

				T. Samson, C. Will, A. Knoblauch, L. Sharek, K. von der Mark, K. Burridge, and V. Wixler Def-6, a Guanine Nucleotide Exchange Factor for Rac1, Interacts with the Skeletal Muscle Integrin Chain {alpha}7A and Influences Myoblast Differentiation J. Biol. Chem., May 25, 2007; 282(21): 15730 - 15742. [Abstract] [Full Text] [PDF]

				M. D. Boppart, D. J. Burkin, and S. J. Kaufman {alpha}7beta1-Integrin regulates mechanotransduction and prevents skeletal muscle injury Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1660 - C1665. [Abstract] [Full Text] [PDF]

				C. Guo, M. Willem, A. Werner, G. Raivich, M. Emerson, L. Neyses, and U. Mayer Absence of {alpha}7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy Hum. Mol. Genet., March 15, 2006; 15(6): 989 - 998. [Abstract] [Full Text] [PDF]

				T. A. H. Jarvinen, T. L. N. Jarvinen, M. Kaariainen, H. Kalimo, and M. Jarvinen Muscle Injuries: Biology and Treatment Am. J. Sports Med., May 1, 2005; 33(5): 745 - 764. [Abstract] [Full Text] [PDF]

				M. A. Lopez, U. Mayer, W. Hwang, T. Taylor, M. A. Hashmi, S. R. Jannapureddy, and A. M. Boriek Force transmission, compliance, and viscoelasticity are altered in the {alpha}7-integrin-null mouse diaphragm Am J Physiol Cell Physiol, February 1, 2005; 288(2): C282 - C289. [Abstract] [Full Text] [PDF]

				D. J. Burkin, G. Q. Wallace, D. J. Milner, E. J. Chaney, J. A. Mulligan, and S. J. Kaufman Transgenic Expression of {alpha}7{beta}1 Integrin Maintains Muscle Integrity, Increases Regenerative Capacity, Promotes Hypertrophy, and Reduces Cardiomyopathy in Dystrophic Mice Am. J. Pathol., January 1, 2005; 166(1): 253 - 263. [Abstract] [Full Text] [PDF]

				T. Samson, N. Smyth, S. Janetzky, O. Wendler, J. M. Muller, R. Schule, H. von der Mark, K. von der Mark, and V. Wixler The LIM-only Proteins FHL2 and FHL3 Interact with {alpha}- and {beta}-Subunits of the Muscle {alpha}7{beta}1 Integrin Receptor J. Biol. Chem., July 2, 2004; 279(27): 28641 - 28652. [Abstract] [Full Text] [PDF]

				M.-G. Yeh, B. L. Ziober, B. Liu, G. Lipkina, I. S. Vizirianakis, and R. H. Kramer The {beta}1 Cytoplasmic Domain Regulates the Laminin-binding Specificity of the {alpha}7X1 Integrin Mol. Biol. Cell, September 1, 2003; 14(9): 3507 - 3518. [Abstract] [Full Text] [PDF]

				T. A. H. Jarvinen, L. Jozsa, P. Kannus, T. L. N. Jarvinen, T. Hurme, M. Kvist, M. Pelto-Huikko, H. Kalimo, and M. Jarvinen Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle J. Cell Sci., March 1, 2003; 116(5): 857 - 866. [Abstract] [Full Text] [PDF]